Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Advances in Therapy|December 1, 2018
Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United StatesChristine L Baker, Amol D Dhamane, Jack Mardekian, et al.Journal of Thrombosis and Thrombolysis|March 30, 2019
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare populationAlpesh Amin, Allison Keshishian, Oluwaseyi Dina, et al.Journal of Managed Care & Specialty Pharmacy|August 30, 2018
A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare PopulationAlpesh Amin, Allison Keshishian, Jeffrey Trocio, et al.Journal of Managed Care & Specialty Pharmacy|April 30, 2020
A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare PopulationAlpesh Amin, Allison Keshishian, Jeffrey Trocio, et al.Urology Practice|November 11, 2025
Patient-Reported Outcomes Following UGN-102 Treatment in Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: An Analysis of 3 Clinical TrialsCharles C Peyton, Max Kates, Anagha Nadkarni, et al.Plos One|January 27, 2018
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approachXiaoyan Li, Allison Keshishian, Melissa Hamilton, et al.Thrombosis and Haemostasis|March 17, 2017
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patientsXiaoyan Shawn Li, Steve Deitelzweig, Allison Keshishian, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 16, 2018
Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United StatesSteven Deitelzweig, Jennifer D Guo, Patrick Hlavacek, et al.Stroke|December 21, 2018
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation PatientsGregory Y H Lip, Allison Keshishian, Xiaoyan Li, et al.Plos One|March 26, 2019
Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failureAlpesh Amin, Alessandra B Garcia Reeves, Xiaoyan Li, et al.Pageof 4